Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cetirizine to reduce fumarate-related adverse effects in severe chronic plaque psoriasis
NL-OMON37148Recruiting
- Sponsor
- Erasmus MC
- Start
- Nov 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial of cetirizine and Fumaderm in psoriasis and plaque psoriasis, sponsored by Erasmus MC. Started Nov 2009; status: recruiting.
02
Drugs
cetirizineFumaderm
03
Conditions
psoriasisplaque psoriasis
Beyond the preview
Go deeper on NL-OMON37148.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON37148.